Funding from three leading healthcare investors, with Vivo Capital joining existing investors Nantahala Capital and Abingworth
$10 million capital infusion at closing and $15 million upon positive data to support NDA submission
Additional $35 million capital upon FDA approval to enable commercialization
https://finance.yahoo.com/news/soleno-therapeutics-announces-financing-commitment-130000949.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.